Opportunities Preloader

Please Wait.....

Report

Asia-Pacific Clinical Trials Support Services Market Forecast 2022-2030

Market Report I 2022-09-01 I 175 Pages I Inkwood Research
Discounted by 20% to 2024-05-30

KEY FINDINGS
The Asia-Pacific clinical trials support services market is estimated to surge with an 8.21% CAGR over the assessment period, 2022 and 2030. The availability of high-quality data at a low price and the presence of a huge population drive market growth.
MARKET INSIGHTS
The Asia-Pacific clinical trials support services market growth evaluation entails the analysis of Japan, China, Singapore, South Korea, Taiwan, India, Australia & New Zealand, Thailand, and Rest of Asia-Pacific. In India, clinical trials are surging. Therefore, clinical trial support services are expected to propel in the next few years. Further, in 2020, there were various top therapy areas for industry-sponsored clinical trials in India, which helped to support the demand for clinical trials during the forecast period.
South Korea has emerged as an attractive country to conduct clinical trials because it offers clinical experts who conduct the clinical trials, infrastructure, dense population, supportive government regulations, etc. Sponsors prefer conducting clinical trials in South Korea due to its speed and quality. With the high density of the population, patients are easily available for participation and the advanced hospitals available in the country. South Korea has an added advantage with access to a larger population.
On the other hand, in Taiwan, the development of the international biotechnology industry is increasing rapidly. Different types of research and development have been advanced to the clinical trial stage. Also, the competition is rising between Japan and South Korea, and as a result, the Taiwan government set up a one-stop shop to provide domestic and international partners with key information on Taiwan's clinical trial environment.
COMPETITIVE INSIGHTS
Some key market players include EPS Corporation, CMIC Group, WuXi AppTec, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation caters to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. RISING PREVALENCE OF CHRONIC DISEASE & VIRUS OUTBREAKS
3.1.2. BENEFITS OF CLINICAL TRIAL SUPPORT SERVICES
3.2. KEY RESTRAINTS
3.2.1. AVAILABILITY OF OPEN-SOURCE/FREEWARE SOFTWARE
3.2.2. STRINGENT REGULATIONS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON CLINICAL TRIALS SUPPORT SERVICES MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. VALUE CHAIN ANALYSIS
4.7. KEY BUYING CRITERIA
4.7.1. PERFORMANCE
4.7.2. EASE OF USE
4.7.3. SECURITY
4.7.4. COST-EFFECTIVENESS
4.8. REGULATORY FRAMEWORK
5. MARKET BY PHASE
5.1. PHASE I
5.2. PHASE II
5.3. PHASE III
5.4. PHASE IV
6. MARKET BY SPONSOR
6.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
6.2. MEDICAL DEVICE COMPANIES
6.3. OTHER SPONSORS
7. MARKET BY SERVICE
7.1. CLINICAL TRIAL SITE MANAGEMENT
7.2. ADMINISTRATIVE STAFF
7.3. PATIENT RECRUITMENT MANAGEMENT
7.3.1. PATIENT RECRUITMENT & REGISTRY SERVICES
7.3.2. PATIENT RETENTION
7.3.3. OTHER PATIENT RECRUITMENT MANAGEMENT
7.4. IRB
7.5. DATA MANAGEMENT
7.6. OTHER SERVICES
8. GEOGRAPHICAL ANALYSIS
8.1. ASIA-PACIFIC
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. KEY GROWTH ENABLERS
8.1.3. KEY CHALLENGES
8.1.4. KEY PLAYERS
8.1.5. COUNTRY ANALYSIS
8.1.5.1. CHINA
8.1.5.2. JAPAN
8.1.5.3. INDIA
8.1.5.4. SOUTH KOREA
8.1.5.5. TAIWAN
8.1.5.6. SINGAPORE
8.1.5.7. THAILAND
8.1.5.8. AUSTRALIA & NEW ZEALAND
8.1.5.9. REST OF ASIA-PACIFIC
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. ADVANCED CLINICAL
9.2.2. ALCURA
9.2.3. CHARLES RIVER LABORATORIES INC
9.2.4. CLINIPACE
9.2.5. CTI CLINICAL TRIAL AND CONSULTING SERVICES INC
9.2.6. ICON PLC
9.2.7. IQVIA
9.2.8. KCR
9.2.9. LABCORP DRUG DEVELOPMENT
9.2.10. MEDPACE
9.2.11. PAREXEL
9.2.12. PSI CRO
9.2.13. SYNEOS HEALTH
9.2.14. WORLDWIDE CLINICAL TRIALS
9.2.15. WUXI APPTEC


TABLE 1: MARKET SNAPSHOT - CLINICAL TRIALS SUPPORT SERVICES
TABLE 2: LIST OF PANDEMIC OUTBREAKS
TABLE 3: LIST OF OPEN-SOURCE SOFTWARE
TABLE 4: LIST OF PARTNERSHIPS
TABLE 5: LAUNCH OF MEDICAL DRUGS
TABLE 6: PROMISING ACQUISITIONS IN THE INDUSTRY
TABLE 7: REGULATORY FRAMEWORK
TABLE 8: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 14: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 16: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 17: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 18: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET
TABLE 19: LIST OF MERGERS & ACQUISITIONS
TABLE 20: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 21: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 22: LIST OF BUSINESS EXPANSIONS & DIVESTITURES



FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PHASE, IN 2021
FIGURE 8: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2030 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2030 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2030 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2030 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SPONSOR, IN 2021
FIGURE 13: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2030 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2030 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2030 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SERVICE, IN 2021
FIGURE 17: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE STAFF, 2022-2030 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PATIENT RECRUITMENT MANAGEMENT, IN 2021
FIGURE 21: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT & REGISTRY SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RETENTION, 2022-2030 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER PATIENT RECRUITMENT MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 24: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY IRB, 2022-2030 (IN $ MILLION)
FIGURE 25: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 26: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 27: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 28: CHINA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 29: JAPAN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 30: INDIA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 31: SOUTH KOREA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 32: TAIWAN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 33: SINGAPORE CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 34: THAILAND CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 35: AUSTRALIA & NEW ZEALAND CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 36: REST OF ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $1250.00 $1000.00
  • $1500.00 $1200.00
  • $2000.00 $1600.00
  • ADD TO BASKET
  • BUY NOW